betamethasone valerate has been researched along with kh 1060 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gniadecki, R; Kobayasi, T; Serup, J | 1 |
| Gniadecka, M; Gniadecki, R; Serup, J | 1 |
2 other study(ies) available for betamethasone valerate and kh 1060
| Article | Year |
|---|---|
Ultrastructure of murine epidermis treated with the vitamin D3 analogue KH-1060.
Topics: Administration, Cutaneous; Animals; Atrophy; Betamethasone Valerate; Calcitriol; Cell Differentiation; Cell Division; Cytoplasm; Cytoplasmic Granules; Desmosomes; Epidermis; Female; Hyalin; Intermediate Filaments; Keratinocytes; Keratins; Mice; Mice, Hairless; Microscopy, Electron; Mitochondria; Ribosomes | 1995 |
Inhibition of glucocorticoid-induced epidermal and dermal atrophy with KH 1060--a potent 20-epi analogue of 1,25-dihydroxyvitamin D3.
Topics: Animals; Atrophy; Betamethasone Valerate; Calcitriol; Calcium; Epidermis; Female; Glucocorticoids; Glycosaminoglycans; Hydroxyproline; Immunosuppressive Agents; Mice; Mice, Hairless; Mice, Inbred C3H; Skin; Skinfold Thickness; Sulfur Radioisotopes | 1994 |